Nuvation Bio NUVB
NYSE NUVB
$5.55 -0.05 (-0.80%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Gross Profit (2024 - 2025)

Updated

Nuvation Bio (NUVB) recorded Gross Profit of $9.77 million in Q3 2025, compared with -$788,000 a year earlier and up 332.9% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Gross Profit (2024 - 2025) Analysis & Trends

On a TTM basis, Nuvation Bio's Gross Profit came in at $14.51 million as of Sep 30, 2025; for FY2024, it came in at $795,000.

  • Per Business Quant, the preceding three quarters came in at $2.26 million (Q2 2025), $990,000 (Q1 2025) and $1.5 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Nuvation Bio 1.94 Bn 1.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 9.77 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 990,000.00
Dec 31, 2024 1.50 Mn
Sep 30, 2024 -788,000.00
Jun 30, 2024 88,000.00
API Access

Nuvation Bio Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=NUVB&period=max&api_key=YOUR_API_KEY